1 / 155

LUNG TRANSPLANTATION

ISHLT. ISHLT. J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132. LUNG TRANSPLANTATION. Overall. 2011. ISHLT. ISHLT. J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132. NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND PROCEDURE TYPE.

penelope-duncan
Télécharger la présentation

LUNG TRANSPLANTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 LUNG TRANSPLANTATION Overall 2011

  2. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND PROCEDURE TYPE NOTE: This figure includes only the lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as representing changes in the number of lung transplants performed worldwide. 2011

  3. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 AVERAGE CENTER VOLUMELung Transplants: January 1, 2000 - June 30, 2010 2011

  4. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 DISTRIBUTION OF TRANSPLANTS BY CENTER VOLUMELung Transplants: January 1, 2000 - June 30, 2010 2011

  5. LUNG TRANSPLANTS:Transplant Recipient Age by Year of TransplantTransplants: January 1, 1987 – June 30, 2010 ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 2011

  6. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 AGE DISTRIBUTION OF LUNG TRANSPLANT RECIPIENTS(1/1985-6/2010) 2011

  7. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 AGE DISTRIBUTION OF LUNG TRANSPLANT RECIPIENTS BY ERA Transplants with unknown recipient age were excluded from this tabulation. 2011

  8. LUNG TRANSPLANTS:Donor Age by Year of TransplantTransplants: January 1, 1987 – June 30, 2010 ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 2011

  9. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 DONOR AGE DISTRIBUTION FOR LUNG TRANSPLANTS (1/1985-6/2010) 2011

  10. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 DONOR AGE DISTRIBUTION FOR LUNG TRANSPLANTS BY ERA Transplants with unknown donor age were excluded from this tabulation. 2011

  11. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 LUNG TRANSPLANTATION Adult Recipients 2011

  12. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 AGE DISTRIBUTION OF ADULT LUNG TRANSPLANT RECIPIENTS(1/1985-6/2010) 2011

  13. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 AGE DISTRIBUTION OF ADULT LUNG TRANSPLANT RECIPIENTS BY ERA 2011

  14. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 AGE DISTRIBUTION OF ADULT LUNG TRANSPLANT RECIPIENTS BY ERA 2011

  15. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival (Transplants: January 1994 - June 2009) 2011

  16. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATION: Indications(1/1995-6/2010) 2011

  17. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATION: Distribution of Procedure Type for Major Indications(1994-2009) 2011

  18. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONProcedure Type within Indication, by Year 2011

  19. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATION: Indications for Single Lung Transplants (Transplants: January 1995 - June 2010) *Other includes: Pulmonary Fibrosis, Other: 3.4% Sarcoidosis: 1.9% Bronchiectasis: 0.4% Congenital Heart Disease: 0.3% LAM: 0.8% Connective Tissue Disease: 1.0% OB (non-ReTx): 0.6% Miscellaneous: 0.9% 2011

  20. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATION: Indications for Bilateral/Double Lung Transplants (Transplants: January 1995 - June 2010) *Other includes: Pulmonary Fibrosis, Other: 2.9% Sarcoidosis: 3.0% Bronchiectasis: 4.4% Congenital Heart Disease: 1.2% LAM: 1.1% Connective Tissue Disease: 1.3% OB (non-ReTx): 1.3% Miscellaneous: 1.7% 2011

  21. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONMajor Indications By Year (%) 2011

  22. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONMajor Indications By Year (Number) 2011

  23. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTS:AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2010 2011

  24. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTS:DIAGNOSIS DISTRIBUTION BY LOCATION Transplants between January 2000 and June 2010 2011

  25. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTS:DONOR AGE DISTRIBUTION BY LOCATIONTransplants between January 2000 and June 2010 2011

  26. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Era (Transplants: January 1988 – June 2009) 2011

  27. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Age Group(Transplants: January 1990 – June 2009) 2011

  28. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATION Kaplan-Meier Survival by Gender (Transplants: January 1990 – June 2009) 2011

  29. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis(Transplants: January 1990 – June 2009) 2011

  30. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis Conditional on Survival to 3 Months(Transplants: January 1990 – June 2009) 2011

  31. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis Conditional on Survival to 1 Year(Transplants: January 1990 – June 2009) 2011

  32. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival for Eisenmenger’s Syndrome(Transplants: January 1990 – June 2009) 2011

  33. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Procedure Type(Transplants: January 1990 – June 2009)Diagnosis: Alpha-1 Antitrypsin Deficiency 2011

  34. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Procedure Type and Age (Transplants: January 1990 – June 2009)Diagnosis: Alpha-1 Antitrypsin Deficiency 2011

  35. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type(Transplants: January 1990 – June 2009) Diagnosis: Emphysema/COPD 2011

  36. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Age(Transplants: January 1990 – June 2009) Diagnosis: Emphysema/COPD 2011

  37. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type(Transplants: January 1990 – June 2009)Diagnosis: Idiopathic Pulmonary Fibrosis 2011

  38. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type (Transplants: January 1990 – June 2009)Diagnosis: Idiopathic Arterial Pulmonary Hypertension 2011

  39. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2009) Diagnosis: Emphysema/COPD, Single Lung 2011

  40. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2009) Diagnosis: Emphysema/COPD, Double Lung 2011

  41. ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2009) Diagnosis: Cystic Fibrosis, Double Lung ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 2011

  42. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2009) Diagnosis: Idiopathic Pulmonary Fibrosis, Single Lung 2011

  43. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Procedure Type and Era(Transplants: January 1990 – June 2009) Diagnosis: Idiopathic Pulmonary Fibrosis, Double Lung 2011

  44. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Donor CMV status/Recipient CMV status(Transplants: October 1999 – June 2009) 2011

  45. PERCENTAGE OF ADULT LUNG TRANSPLANT RECIPIENTS Experiencing Rejection between Transplant Discharge and 1-Year Follow-UpStratified by Donor/Recipient CMV status (Follow-ups: July 2004 - June 2010) ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 D(-)/R(-): N = 1,110 D(-)/R(+): N = 1,378 D(+)/R(-): N = 1,533 D(+)/R(+): N = 2,463 No comparisons were statistically significant at 0.05 Treated rejection = Recipient was reported to (1) have at least one acute rejection episode that was treated with an anti-rejection agent; or (2) have been hospitalized for rejection. No rejection = Recipient had (i) no acute rejection episodes and (ii) was reported either as not hospitalized for rejection or did not receive anti-rejection agents. 2011 Analysis is limited to patients who were alive at the time of the follow-up

  46. PERCENTAGE OF ADULT LUNG TRANSPLANT RECIPIENTS Experiencing Rejection between Transplant Discharge and 1-Year Follow-Up Stratified by Donor/Recipient CMV status (Follow-ups: July 2004 - June 2010) ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 18-34 35-49 50-59 60-65 >65 Female Male No comparisons were statistically significant at 0.05 except D(+)/R(-) vs. D(+)/R(+): 35-49 (p=0.0147) and 50-59:(p=0.0330) Treated rejection = Recipient was reported to (1) have at least one acute rejection episode that was treated with an anti-rejection agent; or (2) have been hospitalized for rejection. No rejection = Recipient had (i) no acute rejection episodes and (ii) was reported either as not hospitalized for rejection or did not receive anti-rejection agents. 2011 Analysis is limited to patients who were alive at the time of the follow-up

  47. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTS (1997-6/2009)Risk Factors for 1 Year Mortality (N=13,937) Reference group = COPD/Emphysema, Single lung *Other = All diagnoses other than COPD, IPAH, IPF, cystic fibrosis, pulmonary fibrosis,bronchiectasis,alpha-1 antitrypsin deficiency, retransplant and LAM. 2011

  48. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTS (1997-6/2009)Risk Factors for 1 Year Mortality (N=13,937) 2011

  49. ADULT LUNG TRANSPLANTS (1997-6/2009)Risk Factors for 1 Year Mortality ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 (N=13,937) 2011

  50. ISHLT ISHLT J Heart Lung Transplant. 2011 Oct; 30 (10): 1071-1132 ADULT LUNG TRANSPLANTS (1997-6/2009)Borderline Significant Risk Factors for 1 Year Mortality (N=13,937) Reference group = COPD/Emphysema, Single lung *Other = All diagnoses other than COPD, IPAH, IPF, cystic fibrosis, pulmonary fibrosis,bronchiectasis,alpha-1 antitrypsin deficiency, retransplant and LAM. 2011

More Related